Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial (Q42994151)
Jump to navigation
Jump to search
scientific article published in July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial |
scientific article published in July 2010 |
Statements
1 reference
Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial (English)
1 reference
1 reference
1 reference
Deepak L Bhatt
1 reference
Danielle M Brennan
1 reference
S Claiborne Johnston
1 reference
Werner Hacke
1 reference
J Donald Easton
1 reference
Jean-Louis Mas
1 reference
Keith A A Fox
1 reference
CHARISMA Trial Investigators
1 reference
1 July 2010
1 reference
1 reference
Identifiers
1 reference